Article
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.
Nature medicine - 25 Sept 2011
Dorard Coralie, de Thonel Aurélie, Collura Ada, Marisa Laetitia, Svrcek Magali, Lagrange Anaïs, Jego Gaetan, Wanherdrick Kristell, Joly Anne Laure, Buhard Olivier, Gobbo Jessica, Penard-Lacronique Virginie, Zouali Habib, Tubacher Emmanuel, Kirzin Sylvain, Selves Janick, Milano Gérard, Etienne-Grimaldi Marie-Christine, Bengrine-Lefèvre Leila, Louvet Christophe, Tournigand Christophe, Lefèvre Jérémie H, Parc Yann, Tiret Emmanuel, Fléjou Jean-François, Gaub Marie-Pierre, Garrido Carmen, Duval Alex
Abstract excerpt
Heat shock proteins (HSPs) are necessary for cancer cell survival. We identified a mutant of HSP110 (HSP110ΔE9) in colorectal cancer showing microsatellite instability (MSI CRC), generated from an aberrantly spliced mRNA and lacking the HSP110 substrate-binding domain. This mutant was expressed at variable levels in almost all MSI CRC cell lines and primary tumors tested. HSP110ΔE9 impaired both the normal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
